These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 413868)

  • 41. Studies on the mechanism by which antigen-specific IgG suppresses primary antibody responses: evidence for epitope masking and decreased localization of antigen in the spleen.
    Getahun A; Heyman B
    Scand J Immunol; 2009 Sep; 70(3):277-87. PubMed ID: 19703017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preferential depression of IgM producing immunocytes during mastocytoma-induced immunosuppression.
    Friedman H; Kamo I
    Proc Soc Exp Biol Med; 1978 Mar; 157(3):381-5. PubMed ID: 416442
    [No Abstract]   [Full Text] [Related]  

  • 43. Pepstatin, an inhibitor of leukokinin formation and ascitic fluid accumulation.
    Greenbaum LM; Grebow P; Johnston M; Prakash A; Semente G
    Cancer Res; 1975 Mar; 35(3):706-10. PubMed ID: 46779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serologic and immunochemical characterization of an immunosuppressive soluble factor from mastocytoma-bearing mice.
    Wantanabe M; Pan SH; Friedman H
    J Natl Cancer Inst; 1978 Jul; 61(1):249-54. PubMed ID: 78985
    [No Abstract]   [Full Text] [Related]  

  • 45. Serologic analyses of an immunosuppressive cell-free factor from mastocytoma cells and neutralization by antiserum.
    Watanabe M
    Tohoku J Exp Med; 1979 Jun; 128(2):151-9. PubMed ID: 111372
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunosuppressive activity of ascitic fluid from patients with cancer metastatic to the peritoneum.
    Badger AM; Cooperband SR; Merluzzi VJ; Glasgow AH
    Cancer Res; 1977 Apr; 37(4):1220-6. PubMed ID: 139204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.
    Biddison WE; Palmer JC
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):329-33. PubMed ID: 402006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RES blockade: effects on immunity and tolerance.
    Friedman H; Sabet TY
    Adv Exp Med Biol; 1976; 73 Pt B():27-39. PubMed ID: 998396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Restoration of antibody-forming capacities by PS-K in tumor-bearing mice.
    Nomoto K; Yoshikumi C; Matsunaga K; Fujii T; Takeya K
    Gan; 1975 Aug; 66(4):365-74. PubMed ID: 1183773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A preliminary assessment of relative sensitivities to foreign red blood cell challenges in the northern bobwhite for potential evaluation of immunotoxicity.
    Quinn MJ; McFarland CA; LaFiandra EM; Johnson MS
    J Immunotoxicol; 2009 Sep; 6(3):171-3. PubMed ID: 19552520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mastocytoma-induced suppression of in vitro antibody formation.
    Kamo I; Kateley J; Freidman H
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):883-6. PubMed ID: 805435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunosuppressive factors from mastocytoma cells cultured in serum-free medium.
    Nakamura M; Ishida N; Kamo I
    J Natl Cancer Inst; 1980 Oct; 65(4):759-68. PubMed ID: 6775120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of the antibody response to sheep red blood cells in normal and immunodeficient XID mice by myo-inositol.
    Tyan ML
    Proc Soc Exp Biol Med; 1997 Jul; 215(3):258-63. PubMed ID: 9207861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A modified method to induce immune polyclonal ascites fluid in BALB/c mice using Sp2/0-Ag14 cells.
    Lacy MJ; Voss EW
    J Immunol Methods; 1986 Mar; 87(2):169-77. PubMed ID: 3950427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered immunologic responsiveness in mastocytoma-bearing mice.
    Kamo I; Patel C; Friedman H
    J Natl Cancer Inst; 1976 Feb; 56(2):333-8. PubMed ID: 815558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunosuppression related to ascitic fluid in patients with ovarian carcinoma.
    Marotti T; Hrsak I; Krusić J; Deverić G
    Oncology; 1982; 39(5):298-303. PubMed ID: 7048173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of antisera to sheep erythrocytes, administered to newborn and adult mice, on the primary immune response].
    Malaĭtsev VV
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Nov; 50(11):59-63. PubMed ID: 4782800
    [No Abstract]   [Full Text] [Related]  

  • 58. Suppression of lymphocyte signal transduction by murine mastocytoma ascites.
    Ding L; Isobe K; Yoshida T; Nakashima I
    Microbiol Immunol; 1991; 35(9):767-74. PubMed ID: 1808472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonspecific immune modulating effects of ascites fluid and hyperimmune sera in vivo.
    Nagase F; Ponzio NM; Waltenbaugh C; Katz I; Thorbecke GJ
    Cell Immunol; 1985 Jan; 90(1):92-102. PubMed ID: 3871366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The macrophage response in mice after primary and secondary immunization with sheep red blood cells.
    Reikvam A
    Acta Pathol Microbiol Scand C; 1976 Jun; 84(3):161-7. PubMed ID: 998264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.